纳米载体介导RNA输送平台作为肝病治疗的前沿战略:挑战和机遇
Jinhui Fan1, Zhicheng Xiao1, Yafen Dong2
1School of Medicine, 411 Hospital of Shanghai University, Shanghai University, Shanghai, 200444, China.
Advanced healthcare materials
|December 26, 2024
概括
RNA疗法对肝脏疾病有前途,但面临着传递挑战. 纳米级平台对于克服RNA不稳定性和改善有效治疗肝病的生物可用性至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 纳米医学是一种纳米医学.
- 在RNA治疗方面,RNA疗法.
背景情况:
- 肝脏疾病对全球健康构成重大挑战,需要新的治疗策略.
- 基于RNA的疗法 (mRNA,siRNA,miRNA,aptamers) 在治疗肝脏疾病方面表现有前途.
- 目前的RNA疗法受到不良稳定性,低生物可用性和核酶降解 in vivo 的限制.
研究的目的:
- 审查肝脏疾病和当前的RNA治疗方法.
- 总结各种纳米级输送平台用于RNA疗法.
- 讨论这些交付系统的现状和未来前景.
主要方法:
- 关于肝脏疾病和RNA疗法的文献综述.
- 对RNA的不同纳米级输送平台的分析.
- 评估各种交付系统的优缺点.
主要成果:
- 目前正在探索各种纳米级输送系统用于RNA疗法.
- 这些平台旨在增强RNA稳定性,生物可用性和目标组织度.
- 每个平台都有独特的优势和临床应用的局限性.
结论:
- 有效的纳米级输送平台对于在肝脏疾病中推进RNA疗法至关重要.
- 克服RNA不稳定性和改善输送是临床成功的关键.
- 对纳米输送系统的持续研究对未来的肝病治疗有很大的前景.
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K


